Electromed/ELMD

$15.14

-2.32%
-
1D1W1MYTD1YMAX

About Electromed

Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. The Company applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. Its SmartVest Connect wireless technology is a personalized HFCWO therapy management portal for patients with compromised pulmonary function. The SmartVest Connect app securely connects to the SmartVest System through Bluetooth technology. The Company also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.

Ticker

ELMD

Sector

Healthcare

Trading on

AMEX

Industry

Medical Equipment & Supplies

CEO

James Cunniff

Employees

170

Headquarters

New prague, United States

Electromed Metrics

BasicAdvanced
$128.91M
Market cap
33.31
P/E ratio
$0.45
EPS
0.41
Beta
-
Dividend rate

What the Analysts think about Electromed

Analyst Ratings

Majority rating from 1 analysts.
Buy

Price Targets

Average projection from 1 analysts.
71.73% upside
High $26.00
Low $26.00
$15.14
Current price
$26.00
Average price target

Electromed Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
11.76% profit margin
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$13.6M
10.57%
Net income
$1.6M
1,500%
Profit margin
11.76%
1,351.85%

Electromed Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 90%
QuarterlyAnnual
Q3 23
Q4 23
Q1 24
Q2 24
Q3 24
Actual
$0.12
$0.12
$0.02
$0.19
-
Expected
$0.10
$0.13
$0.10
$0.10
$0.13
Surprise
20%
-7.69%
-80%
90%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Electromed stock

Buy or sell Electromed stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing